Sunpointe’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Sunpointe's AMGN Position: Q1 2026 in Review
Sunpointe increased its Amgen (AMGN) stake by 9.3% in Q1 2026, buying an estimated $44.6K and bringing the position to 1,466 shares worth $516K. The position accounts for 0.17% of the portfolio, ranked #130.
Sunpointe first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Sunpointe held 1,466 shares of Amgen worth $516K as of Q1 2026.
- Sunpointe bought 125 Amgen shares in Q1 2026, an estimated $44.6K.
- Amgen made up 0.17% of Sunpointe's portfolio in Q1 2026, its #130 holding.
- Sunpointe first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Sunpointe's 13F filing for Q1 2026, filed 21 Apr 2026.